tnx-901
mAbexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Ig epsilon chain C regionINHIBITOR
IGHE inhibitor
Humanized IgG1 monoclonal antibody against IgE that recognizes and masks an epitope in the CH3 region of IgE responsible for binding to the high-affinity Fc(epsilon) receptor on mast cells and basophils.
- Immunoglobulin epsilon heavy chainINHIBITOR
Immunoglobulin epsilon heavy chain inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109455 ↗
- ChEMBLCHEMBL2107888 ↗
Also known as
- al-901
- c21/al-90
- hu-901
- talizumab
- talizumab
- tnx901
- tnx-901
- tnx-901
- tnx-901